Commonwealth Equity Services LLC lessened its holdings in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 24.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,062 shares of the business services provider’s stock after selling 983 shares during the period. Commonwealth Equity Services LLC’s holdings in Exponent were worth $291,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. GAMMA Investing LLC boosted its position in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in Exponent by 866.0% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock valued at $42,000 after purchasing an additional 459 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its position in Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after purchasing an additional 323 shares during the last quarter. Janiczek Wealth Management LLC boosted its position in Exponent by 293.7% during the first quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock valued at $52,000 after purchasing an additional 467 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in Exponent during the first quarter valued at $75,000. Institutional investors and hedge funds own 92.37% of the company’s stock.
Exponent Trading Up 1.4 %
EXPO opened at $112.78 on Wednesday. Exponent, Inc. has a 1 year low of $64.61 and a 1 year high of $113.54. The stock has a fifty day moving average price of $105.70 and a 200 day moving average price of $95.21. The stock has a market cap of $5.72 billion, a price-to-earnings ratio of 56.96 and a beta of 0.66.
Exponent Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, September 20th. Shareholders of record on Friday, September 6th were given a $0.28 dividend. The ex-dividend date of this dividend was Friday, September 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.99%. Exponent’s dividend payout ratio is currently 56.57%.
Analyst Ratings Changes
Separately, Truist Financial reissued a “buy” rating and set a $120.00 price objective (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.
Read Our Latest Stock Report on Exponent
Insiders Place Their Bets
In other Exponent news, VP John Pye sold 3,956 shares of the business’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the completion of the sale, the vice president now owns 28,422 shares of the company’s stock, valued at $2,984,310. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 2.10% of the company’s stock.
Exponent Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- The 3 Best Fintech Stocks to Buy Now
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Roth IRA Calculator: Calculate Your Potential Returns
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a Bond Market Holiday? How to Invest and Trade
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.